https://doi.org/10.4081/reumatismo.2019.1252
Erysipelas-like presentation of Wells’ syndrome (eosinophilic cellulitis)
Accepted: 19 October 2019
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Wells’ syndrome, also called eosinophilic cellulitis, is a rare eosinophilic dermatosis characterized by an unspecific inflammatory erythematous eruption often associated with systemic symptoms. Here we report the case of a 57-year-old female with bilateral painful pitting and pruritic feet progressive for two weeks despite one week of oral antibiotics. Skin biopsy was performed showing dermal eosinophilic infiltration. The patient showed a spontaneous progressive improvement of the condition. The presented case demonstrates both clinical and histologic presence of lesions of Wells’ syndrome in the course of the disease. A careful diagnostic approach is needed because of the lack of specific signs. The global outcome is favorable and spontaneous resolution is possible.
How to Cite
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
Similar Articles
- R. Assari, P. Sadeghi, A. Mirmohammadsadeghi, F. Ebadi, V. Ziaee, Macrophage activation syndrome as a complication of rheumatologic disorders, a report from Iran , Reumatismo: Vol. 71 No. 4 (2019)
- V. Gerloni, I. Pontikaki, M Gattinara, F. Fantini, Biological therapy with TNF-inhibitors in pediatric rheumatology. Review of the litterature and personal experience , Reumatismo: Vol. 59 No. 3 (2007)
- M. Cutolo, M. Olivieri, M.E. Secchi, M.A. Cimino, Therapy of rheumatic polymyalgia: the pathophysiologic management , Reumatismo: Vol. 59 No. 4 (2007)
- M. Cazzola, P. Sarzi-Puttini, D. Buskila, F. Atzeni, Pharmacological treatment of fibromyalgia , Reumatismo: Vol. 59 No. 4 (2007)
- S.H. Sánchez-Rodríguez, D. Herrera-van-Oostdam, E. Avalos-Díaz, R. Herrera-Esparza, Ro60 and La ribonucleoproteins become self-aggregated by cell stress , Reumatismo: Vol. 59 No. 4 (2007)
- M. Mosca, C. Tani, C. Neri, A. Della Rossa, C. Baldini, R. Talarico, L. Carli, S. Bombardieri, Analysis of the evolution to defined connective tissue diseases of patients with “early unidifferentiated connective tissue diseases (UCTD)” , Reumatismo: Vol. 60 No. 1 (2008)
- L. Andreoli, C. Nalli, M. Motta, G.L. Norman, W.L. Binder, M. Nuzzo, M. Frassi, A. Lojacono, T. Avcin, P.L. Meroni, A. Tincani, Subpopulations of anti-β2glycoprotein I antibodies with different pathogenic potential: fine specificity against the domains of β2glycoprotein I , Reumatismo: Vol. 62 No. 3 (2010)
- S. Olivieri, A. Ruffatti, A. Bontadi, A. Cavazzana, E. Salvan, S. Cuffaro, S. Giunco, L. Punzi, Clinical value of antibodies to lysobisphosphatidic acid in patients with primary antiphospholipid sindrome , Reumatismo: Vol. 62 No. 2 (2010)
- F. Atzeni, P. Sarzi-Puttini, B-cell depletion and primary Sjögren’s syndrome: is there a role for rituximab? , Reumatismo: Vol. 62 No. 2 (2010)
- P. Sarzi- Puttini, F. Atzeni, S. Stisi, M. Cazzola, Fibromialgia: chi deve rimodulare la percezione del dolore in questi pazienti? , Reumatismo: Vol. 60 No. s1 (2008)
<< < 12 13 14 15 16 17 18 19 20 > >>
You may also start an advanced similarity search for this article.
